CLOT
Nov 24, 2020•16 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The Landmarks in OncoPharm series returns to discuss the practice-changing CLOT trial of a LMWH vs. a vitamin K antatogist for treating cancer-associated VTE.
CLOT: https://www.nejm.org/doi/full/10.1056/nejmoa025313
For the best experience, listen in Metacast app for iOS or Android